10,000+ stock pitches from top investors available on joinyellowbrick.com
Redmile Group, LLC 13F Holdings
Holdings from the most recent 13F from Redmile Group, LLC
Filed: 2020-05-15 (Q1 2020) | Holdings: 69 | Value: $3.6B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
---|---|---|---|---|---|---|---|
Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
FATE - FATE THERAPEUTICS INC | 6.98% | $249.1M | -95.98% | +18.12% | +153.87% | ||
FOLD - AMICUS THERAPEUTICS INC | 6.52% | $232.7M | -53.64% | +20.63% | -25.32% | ||
DCPH - DECIPHERA PHARMACEUTICALS IN | Add 9% ($16.7M) | 5.91% | $210.6M | -15.75% | -37.24% | ||
BIIB - BIOGEN INC | Add 29% ($41.7M) | 5.23% | $186.4M | -60.94% | -10.75% | -13.46% | |
IGMS - IGM BIOSCIENCES INC | 4.95% | $176.5M | -98.11% | -15.81% | +10.05% | ||
ARGX - ARGENX SE | Reduce 6% $(9.4M) | 4.00% | $142.5M | +242.28% | +51.64% | +76.66% | |
MNTA - MOMENTA PHARMACEUTICALS INC | Add 60% ($52.7M) | 3.95% | $140.8M | -9.48% | |||
EPZM - EPIZYME INC | 3.81% | $136.0M | -31.59% | -50.85% | |||
PRNB - PRINCIPIA BIOPHARMA INC | Reduce 17% $(27.4M) | 3.76% | $134.3M | +54.00% | |||
ALLK - ALLAKOS INC | Reduce 2% $(2.5M) | 3.71% | $132.4M | +32.05% | +46.35% | ||
QURE - UNIQURE NV | Add 9% ($10.4M) | 3.69% | $131.6M | -74.69% | -31.01% | -46.84% | |
APRE - APREA THERAPEUTICS INC | 2.21% | $78.9M | |||||
RGNX - REGENXBIO INC | Reduce 7% $(5.5M) | 2.12% | $75.7M | -78.41% | -17.76% | -12.49% | |
SGEN - SEATTLE GENETICS INC | New Purchase | 2.12% | $75.7M | -0.36% | -8.88% | ||
NVRO - NEVRO CORP | Reduce 25% $(23.3M) | 1.98% | $70.6M | +11.04% | +18.63% | ||
MRK - MERCK & CO. INC | New Purchase | 1.70% | $60.7M | +20.89% | +5.47% | +1.79% | |
BEAM - BEAM THERAPEUTICS INC | New Purchase | 1.70% | $60.5M | -24.49% | +1.33% | +207.33% | |
UNH - UNITEDHEALTH GROUP INC | Add 19% ($9.5M) | 1.69% | $60.1M | +11.55% | +7.84% | +39.05% | |
IMGN - IMMUNOGEN INC | Add 14% ($7.1M) | 1.60% | $57.1M | -18.72% | +47.80% | ||
TNDM - TANDEM DIABETES CARE INC | Reduce 25% $(18.7M) | 1.59% | $56.7M | -77.33% | +13.09% | -12.74% | |
ONEM - 1LIFE HEALTHCARE INC | New Purchase | 1.59% | $56.7M | -13.09% | -1.41% | ||
NVS - NOVARTIS A G | Add 14% ($6.6M) | 1.51% | $53.9M | +63.87% | +1.55% | +6.99% | |
CI - CIGNA CORP NEW | Add 104% ($27.1M) | 1.49% | $53.3M | +74.16% | -6.68% | +36.16% | |
STOK - STOKE THERAPEUTICS INC | Add 112% ($26.2M) | 1.39% | $49.6M | -55.72% | +9.87% | +34.67% | |
CNC - CENTENE CORP DEL | Reduce 47% $(43.3M) | 1.37% | $49.0M | -20.65% | -7.74% | +1.53% | |
TCDA - TRICIDA INC | 1.31% | $46.8M | -53.25% | -84.79% | |||
NLTX - NEOLEUKIN THERAPEUTICS INC | Add 110% ($24.1M) | 1.29% | $46.0M | ||||
KRYS - KRYSTAL BIOTECH INC | Reduce 4% $(1.7M) | 1.28% | $45.5M | +120.15% | -25.32% | +11.48% | |
ATRA - ATARA BIOTHERAPEUTICS INC | Add 14% ($5.5M) | 1.26% | $45.0M | -97.15% | +10.94% | +27.85% | |
AXNX - AXONICS MODULATION TECHNOLOG | Reduce 2% $(625.1K) | 1.07% | $38.3M | +22.01% | +50.85% | ||
PRAH - PRA HEALTH SCIENCES INC | Reduce 2% $(589.6K) | 1.03% | $36.8M | +6.05% | +78.52% | ||
SRRK - SCHOLAR ROCK HLDG CORP | Reduce 2% $(615.2K) | 0.98% | $35.0M | +107.66% | -23.04% | +62.44% | |
DXCM - DEXCOM INC | New Purchase | 0.98% | $34.8M | -23.76% | +3.74% | -23.44% | |
EIDX - EIDOS THERAPEUTICS INC | Reduce 2% $(573.2K) | 0.95% | $33.8M | +1.13% | |||
GMAB - GENMAB A/S | Add 65% ($13.0M) | 0.92% | $32.8M | -26.01% | +28.79% | +31.02% | |
AMED - AMEDISYS INC | Reduce 2% $(642.4K) | 0.91% | $32.6M | -48.10% | +23.80% | +33.23% | |
CYRX - CRYOPORT INC | New Purchase | 0.87% | $31.0M | -71.88% | +35.26% | +106.55% | |
ZYME - ZYMEWORKS INC | New Purchase | 0.86% | $30.8M | -66.76% | -20.87% | -21.76% | |
REPL - REPLIMUNE GROUP INC | Add 8% ($2.1M) | 0.83% | $29.7M | -54.72% | +15.89% | +69.08% | |
WVE - WAVE LIFE SCIENCES LTD | Reduce 12% $(3.7M) | 0.77% | $27.4M | -35.99% | -15.49% | -42.49% | |
CTLT - CATALENT INC | New Purchase | 0.74% | $26.3M | +21.37% | +36.03% | ||
PPD - PPD INC | New Purchase | 0.64% | $23.0M | +11.46% | +63.99% | ||
ARDX - ARDELYX INC | Reduce 2% $(545.2K) | 0.62% | $22.2M | -52.50% | -22.30% | -10.13% | |
ODTC - ODONATE THERAPEUTICS INC | Reduce 10% $(2.3M) | 0.55% | $19.5M | +22.48% | -89.22% | ||
BCEL - ATRECA INC | New Purchase | 0.52% | $18.7M | -26.64% | -52.33% | ||
SWAV - SHOCKWAVE MED INC | Reduce 2% $(335.1K) | 0.52% | $18.5M | +26.93% | +263.70% | ||
TWST - TWIST BIOSCIENCE CORP | New Purchase | 0.51% | $18.0M | -12.25% | +72.52% | +129.12% | |
GRTS - GRITSTONE ONCOLOGY INC | Reduce 2% $(281.7K) | 0.50% | $17.9M | -50.00% | +30.03% | ||
HOOK - HOOKIPA PHARMA INC | Reduce 2% $(247.6K) | 0.43% | $15.4M | -98.64% | +5.21% | +88.33% | |
TCRR - TCR2 THERAPEUTICS INC | Reduce 2% $(246.9K) | 0.38% | $13.7M | +99.79% | +104.13% | ||
AKRO - AKERO THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
ELV - ANTHEM INC | Reduce 100% | 0.00% | $0.00 | +50.77% | -0.34% | +39.95% | |
BOLD - AUDENTES THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
BSX - BOSTON SCIENTIFIC CORP | Reduce 100% | 0.00% | $0.00 | +153.52% | +10.04% | +16.67% | |
BMY - BRISTOL MYERS SQUIBB CO | Reduce 100% | 0.00% | $0.00 | +7.18% | -1.25% | +3.99% | |
CABA - CABALETTA BIO INC | Reduce 100% | 0.00% | $0.00 | -46.57% | +69.93% | +30.63% | |
FTSV - FORTY SEVEN INC | Reduce 100% | 0.00% | $0.00 | ||||
GH - GUARDANT HEALTH INC | Reduce 100% | 0.00% | $0.00 | -63.84% | -10.38% | +14.38% | |
HCA - HCA HEALTHCARE INC | Reduce 100% | 0.00% | $0.00 | +230.11% | +31.00% | +104.86% | |
PTCT - PTC THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
XERS - XERIS PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 |